98 related articles for article (PubMed ID: 26629123)
1. Correlation between CYP4F2 gene rs2108622 polymorphism and susceptibility to ischemic stroke.
Meng C; Wang J; Ge WN; Tang SC; Xu GM
Int J Clin Exp Med; 2015; 8(9):16122-6. PubMed ID: 26629123
[TBL] [Abstract][Full Text] [Related]
2. Association of the CYP4F2 rs2108622 genetic polymorphism with hypertension: a meta-analysis.
Luo XH; Li GR; Li HY
Genet Mol Res; 2015 Nov; 14(4):15133-9. PubMed ID: 26634476
[TBL] [Abstract][Full Text] [Related]
3. Impact of the
Sun X; Yu WY; Ma WL; Huang LH; Yang GP
Biomed Rep; 2016 Apr; 4(4):498-506. PubMed ID: 27073641
[TBL] [Abstract][Full Text] [Related]
4. Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke.
Munshi A; Sharma V; Kaul S; Al-Hazzani A; Alshatwi AA; Shafi G; Koppula R; Mallemoggala SB; Jyothy A
Mol Biol Rep; 2012 Feb; 39(2):1677-82. PubMed ID: 21625857
[TBL] [Abstract][Full Text] [Related]
5. Association Between the
Geng H; Li B; Wang Y; Wang L
Genet Test Mol Biomarkers; 2019 May; 23(5):342-347. PubMed ID: 30932691
[No Abstract] [Full Text] [Related]
6. Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.
Athinarayanan S; Wei R; Zhang M; Bai S; Traber MG; Yates K; Cummings OW; Molleston J; Liu W; Chalasani N
PLoS One; 2014; 9(4):e95366. PubMed ID: 24759732
[TBL] [Abstract][Full Text] [Related]
7. CYP4F2 gene single nucleotide polymorphism is associated with ischemic stroke.
Yan HQ; Yuan Y; Zhang P; Huang Z; Chang L; Gui YK
Genet Mol Res; 2015 Jan; 14(1):659-64. PubMed ID: 25730002
[TBL] [Abstract][Full Text] [Related]
8. The frequency of cytochrome 4F2 rs2108622 genetic variant and its effects on the lipid profile and complications of type II diabetes among a sample of patients in Jordan: A pilot study.
Jarrar Y; Alkhalili M; Alhawari H; Abaalkhail SJ; Alkhalili S; Alhawari H; Momani M; Obeidat AN; Fram RK
Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106715. PubMed ID: 36758722
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variants of
Huang K; Ma T; Li Q; Zhou Y; Qin T; Zhong Z; Tang S; Zhang W; Zhong J; Lu S
Pharmgenomics Pers Med; 2023; 16():599-607. PubMed ID: 37342180
[TBL] [Abstract][Full Text] [Related]
10. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure.
Fava C; Montagnana M; Almgren P; Rosberg L; Lippi G; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
Hypertension; 2008 Aug; 52(2):373-80. PubMed ID: 18574070
[TBL] [Abstract][Full Text] [Related]
11. Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level.
Liao D; Yi X; Zhang B; Zhou Q; Lin J
Genet Test Mol Biomarkers; 2016 May; 20(5):223-8. PubMed ID: 26959478
[TBL] [Abstract][Full Text] [Related]
12. Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population.
Ding H; Cui G; Zhang L; Xu Y; Bao X; Tu Y; Wu B; Wang Q; Hui R; Wang W; Dackor RT; Kissling GE; Zeldin DC; Wang DW
Pharmacogenet Genomics; 2010 Mar; 20(3):187-94. PubMed ID: 20130494
[TBL] [Abstract][Full Text] [Related]
13. Computational analysis of missense variant CYP4F2*3 (V433M) in association with human CYP4F2 dysfunction: a functional and structural impact.
Farajzadeh-Dehkordi M; Mafakher L; Samiee-Rad F; Rahmani B
BMC Mol Cell Biol; 2023 May; 24(1):17. PubMed ID: 37161313
[TBL] [Abstract][Full Text] [Related]
14. Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.
Bejarano-Achache I; Levy L; Mlynarsky L; Bialer M; Muszkat M; Caraco Y
Clin Ther; 2012 Apr; 34(4):811-23. PubMed ID: 22417713
[TBL] [Abstract][Full Text] [Related]
15. Interethnic variability of CYP4F2 (V433M) in admixed population of Roma and Hungarians.
Sipeky C; Weber A; Melegh BI; Matyas P; Janicsek I; Szalai R; Szabo I; Varnai R; Tarlos G; Ganczer A; Melegh B
Environ Toxicol Pharmacol; 2015 Jul; 40(1):280-3. PubMed ID: 26176903
[TBL] [Abstract][Full Text] [Related]
16. The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes.
Fava C; Montagnana M; Danese E; Sjögren M; Almgren P; Guidi GC; Hedblad B; Engström G; Minuz P; Melander O
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):31-6. PubMed ID: 22484021
[TBL] [Abstract][Full Text] [Related]
17. Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate.
Tippin T; Faison S; Schuck V; Dunn J; Naderer O
Clin Pharmacol Drug Dev; 2024 Mar; 13(3):288-296. PubMed ID: 38171911
[TBL] [Abstract][Full Text] [Related]
18. Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy.
Zhang JE; Jorgensen AL; Alfirevic A; Williamson PR; Toh CH; Park BK; Pirmohamed M
Pharmacogenet Genomics; 2009 Oct; 19(10):781-9. PubMed ID: 19741565
[TBL] [Abstract][Full Text] [Related]
19. Peripheral and central augmentation indexes in relation to the CYP4F2 polymorphisms in Chinese.
Hu BC; Li Y; Li FH; Zhang Y; Sheng CS; Fan HQ; Wang JG
J Hypertens; 2011 Mar; 29(3):501-8. PubMed ID: 21150635
[TBL] [Abstract][Full Text] [Related]
20. Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients.
Chen P; Sun YQ; Yang GP; Li R; Pan J; Zhou YS
Saudi Med J; 2016 Apr; 37(4):361-8. PubMed ID: 27052278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
